NEW DELHI/DAVOS: Amid concerns about COVID-19 vaccines not reaching all parts of the world, especially to poor countries, a top WHO official on Tuesday said vaccination must be central to any strategy to fight the pandemic and equitable distribution is a must.
While some of the developed nations are talking about the fourth dose of the vaccine, a large number of people in Africa and some other regions are yet to get their first one.
Speaking at a panel discussion on 'Meeting the challenges of vaccine equity' at the World Economic Forum's online Davos Agenda 2022 summit, leaders said the rapid development of COVID-19 vaccines is a scientific achievement for the ages. But the failure to ensure universal global distribution risks not only bad health outcomes but also economic upheaval and geopolitical tensions, they opined.
Continue reading your story on the app
Continue reading your story in the newspaper
Amendments To National Policy On Biofuels Will Boost ‘Make In India', Says PM Modi
Prime Minister Narendra Modi said on Wednesday that amendments to the National Policy on Biofuels, which have been approved by the Cabinet, will encourage research in developing indigenous technologies, boost ‘Make in India’ and create employment opportunities.
IIFA Awards advanced to June’s first week
Bollywood superstar Salman Khan and Riteish Deshmukh will host the much-anticipated event
WB ‘took a bunch out of my role’ from ‘Aquaman 2’: Amber
WB, the banner behind ‘Aquaman’ franchise, ‘did not want to include’ her in the film
‘RBI opted off-cycle rate hike to avoid tougher action in June’
The RBI Governor says as several storms hit together, ‘our monetary policy response should be seen as an important step to steady the ship’
Cabinet enables boards of PSEs to decide on closure, divestment
‘For strategic disinvestment, such guiding principles will be laid down by DIPAM. For closure, DPE shall issue guiding principles,’ statement said
Perarivalan’s kin on cloud nine; Stalin, others hail SC ruling
Political parties, including DMK and AIADMK, barring Congress and BJP, wholeheartedly welcomed the verdict
Pollution led to over 23.5 lakh premature deaths in India in 2019: Lancet study
It’s the highest among all countries globally, says report
SC grants bail to Indrani Mukerjea
SHEENA BORA MURDER CASE
SC rules out branches of NGT in all states and UTs
Holds that the provision of an appeal directly in SC against an order of NGT was intra-vires and does not oust high courts' power under writ jurisdictions
Heavy rains in Bengaluru: 2 labourers die, houses inundated
Showers continue in Kerala, Red alert in 4 districts
The Real Vaccine Billionaires of Maharashtra
An Indian racehorse dynasty may be the world’s best hope for producing enough vaccine to end the pandemic
Make Tesla cars in India: Poonawalla advises Elon Musk
"I assure you this will be the best investment you'll ever make."
Booster dose can save lives in future waves, says Poonawalla
Vaccination Programme Puts India In A Good Position'
Covishield booster to cost ₹600 per dose, says Poonawalla
The Covishield booster dose will cost ₹600 plus taxes at private vaccination centres, Serum Institute of India's chief executive officer Adar Poonawalla announced on Friday, after the government opened up precaution doses for all adults in the country, adding that the company's second Covid-19 vaccine Covovax will cost ₹900 plus taxes once approved by the National Technical Advisory Group on Immunisation (NTAGI) for use under the government's immunisation programme.
THE VACCINE CHAMPIONS
With their extraordinary foresight, initiative and courage, Covid vaccine manufacturers Krishna Ella of Bharat Biotech and Adar Poonawalla of Serum Institute helped India avert a certain health catastrophe. The inside story of how they did it
Boosters a proven strategy to raise antibodies: Adar
A new, more effective vaccine against the Omicron variant of Covid-19 is in the works but a booster dose will definitely provide adequate protection against the variant, Serum Institute of India (SII) Chief Executive Officer Adar Poonawalla said on Tuesday.
POONAWALLA FINCORP POTENTIAL TO OUTPACE NATIONAL GROWTH
The company is a diversified asset financier both in term of products as well as geographies, which helps mitigate risks. It possesses a sound business model with a presence in high-yield, high-growth business segments and superior sustainable returns
Forbes INDIA Leadership Awards 2020-21
In a year when business leaders were forced to overhaul their strategies from growth to survival mode, the Forbes India Leadership Awards honour those who successfully navigated the pandemic by innovating and leading from the front
SHOT AT SUCCESS
Adar Poonawalla is betting big that his family’s Serum Institute of India will be among the first to produce Covid-19 vaccines.
India to get 100m shots from Serum by next mth
Pune Vaccine Maker May Get Emergency OK From Govt By Dec